A novel model might predict the risk of chronic atrophic gastritis: a multicenter prospective study in China

References

• Melton SD, Genta RM, Souza RF. Biomarkers and molecular diagnosis of gastrointestinal and pancreatic neoplasms. Nat Rev Gastroenterol Hepatol 2010;7:620–8.
   PubMed Web of Science ®Google Scholar
• Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74–108.
   PubMed Web of Science ®Google Scholar
• Kim N, Jung HC. The role of serum pepsinogen in the detection of gastric cancer. Gut Liver 2010;4:307–19.
   Google Scholar
• Kurosawa M, Kikuchi S, Inaba Y, Ishibashi T, Kobayashi F. Helicobacter pylori infection among Japanese children. J Gastroenterol Hepatol 2000;15:1382–5.
   PubMed Web of Science ®Google Scholar
• Kitahara F, Shimazaki R, Sato T, Kojima Y, Morozumi A, Masayuki A, Severe atrophic gastritis with Helicobacter pylori infection and gastric cancer. Gastric Cancer 1998;1:118–24.
   PubMedGoogle Scholar
• Fung WP, Lee SK, Tye CY. The prevalence of chronic gastritis in patients with gastric ulcer. Aust N Z J Med 1975;5:133–7.
   PubMedGoogle Scholar
• Parsonner J, Harris RA, Hack HM, Owens DK. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Lancet 1996;348:150–5.
   PubMed Web of Science ®Google Scholar
• Yoshihara M, Hiyama T, Yoshida S, Ito M, Tanaka S, Watanabe Y, Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration: a case-control study. Scand J Gastroenterol 2007;42:760–4.
   PubMed Web of Science ®Google Scholar
• Miki K, Ichinose M, Ishikawa KB, Yahagi N, Matsushima M, Kakei N, Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer. Jpn J Cancer Res 1993;84:1086–90.
   PubMedGoogle Scholar
• Yoshihara M, Sumii K, Haryma K, Kiyohira K, Hattori N, Kitadai Y, Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. AM J Gastroenterol 1998;93:1090–6.
   PubMed Web of Science ®Google Scholar
• Miki K, Morita M, Sasajima M, Hoshina R, Kanda E, Urita Y. Usefulness of gastric cancer screening using the serum pepsinogen test method. AM J Gastroenterol 2003;98:735–9.
   PubMed Web of Science ®Google Scholar
• Dinis-Ribeiro M, Yamaki G, Miki K, Costa-Pereira A, Matsukawa M, Kurihara M. Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening. J Med Screen 2004;11:141–7.
   PubMed Web of Science ®Google Scholar
• Ozasa K, Kurata JH, Higashi A, Hayashi K, Inokuchi H, Miki K, Helicobacter pylori infection and atrophic gastritis. A nested case- control study in a rural town in Japan. Dig Dis Sci 1999;44:253–6.
   PubMed Web of Science ®Google Scholar
• Ohkuma K, Okada M, Murayama H, Seo M, Maeda K, Kanda M, Association of Helicobacter pylori infection with atrophic gastritis and intestinal metaplasia. J Gastroenterol Hepatol 2000;15:1105–12.
   PubMed Web of Science ®Google Scholar
• Tsugane S, Kabuto M, Imai H, Grey F, Tei Y, Hanaoka T, Helicobacter pylori, dietary factors, and atrophic gastritis I five Japanese populations with different gastric cancer mortality. Cancer Causes Control 1993;4:297–305.
   PubMed Web of Science ®Google Scholar
• Chen VW, Abu-Elyazeed RR, Zavala DE, Ktsanes VK, Haenszel W, Cuello C, Risk factors of gastric precancerous lesions in a high-risk Colombian population I. Salt. Nutr Cancer 1990;13:59–65.
   PubMed Web of Science ®Google Scholar
• Ito LS, Oba SM, Hamajima N, Marie SK, Uno M, Shinjo SK, Helicobacter pylori seropositivity among 963 Japanese Brazilians according to sex, age, generation and lifestyle factors. Jpn J Cancer Res 2001;92:1150–6.
   PubMedGoogle Scholar
• Ito LS, Oba-Shinjo SM, Marie SK, Uno M, Shinjo SK, Hamajima N, Lifestyle factors associated with atrophic gastritis among Helicobacter pylori-seropositive Japanese-Brazilians in Sao Paulo. Int J Clin Oncol 2003;8:362–8.
   PubMedGoogle Scholar
• Tytgat Guido N. The Sydney system: endoscopic division. Endoscopic appearance in gastritis/duodenitis. J Gastroenterol Hepatol 1991;6:223–34.
   PubMed Web of Science ®Google Scholar
• Dixon Michael F, Genta Robert M, Yardley John H, Pelayo C. Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol 1996;20:1161–81.
   PubMed Web of Science ®Google Scholar
• Hosmer DW, Lemeshow S. Model-building strategies. In Sons JW, editor. Applied logistic regression. New York: A Wiley Interscience Publication; 1989. p 82–134.
   Google Scholar
• Dodd LE, Pepe MS. Partial AUC estimation and regression. Biometrics 2003;59:614–23.
   PubMed Web of Science ®Google Scholar
• Asaka M, Sugiyama T, Nobuta A, Kato M, Takeda H, Graham DY. Atrophic gastritis and intestinal metaplasia in Japan: results of a large multicenter study. Helicobacter 2001;6:294–9.
   PubMed Web of Science ®Google Scholar
• Dinis-Ribeiro M, Lopes C, da Costa-Pereira A, Guilherme M, A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia. J Clin Pathol 2004;57:177–82.
   PubMed Web of Science ®Google Scholar
• Onodera H, Tokunage A, Yoshiyuki T, Kiyama T, Kato S, Matusukura N, Surgical outcome of 483 patients with gastric cancer: prognosis, postoperative morbidity and mortality and gastric remnant cancer. Hepatogastroenterology 2004;51:82–5.
   PubMedGoogle Scholar
• Inoue M, Tajima K, Kabayashi S, Suzuki T, Matsuura A, Nakamura T, Protective factor against progression from atrophic gastritis to gastric cancer-Data from a cohort study in Japan. Int J Cancer 1996;66:309–14.
   PubMed Web of Science ®Google Scholar
• Jedrychowski W, Popiela T, Drews M, Gabryelewicz A, Marlicz K, Misiunia P, Effect of Helicobacter pylori infection, smoking and dietary habits on the occurrence of antrum intestinal metaplasia. Clinico-epidemiological study in Poland. Pol J Pathol 1999;50:289–95.
   PubMedGoogle Scholar
• Zhao L, Blot WJ, Liu WD, Chang YS, Zhang JS, Hu YR, Familial predisposition to precancerous gastric lesions in a high-risk area of China. Cancer Epidemiol Biomarkers Prev 1994;3:461–4.
   PubMed Web of Science ®Google Scholar
• The Eurohepygast Study Group. Risk factors for atrophic chronic gastritis in a European population: results of the Eurohepygast study. Gut 2002;50:779–85.
   PubMed Web of Science ®Google Scholar
• Setiwan VW, Zhang ZF, Yu GP, Lu QY, Li YL, Lu ML, Protective effect of green tea on the risks of chronic gastritis and stomach cancer. Int J Cancer 2001;92:600–4.
   PubMed Web of Science ®Google Scholar
• Correa P, Haenszel W, Cuello C, Zavala D, Fontham E, Zarama G, Gastric precancerous process in a high risk population: cross-sectional studies. Cancer Res 1990;50:4731–6.
   PubMed Web of Science ®Google Scholar
• Melanie NW, Brenner H. Prevalence of chronic atrophic gastritis in different parts of the world. Cancer Epidemiol Biomarkers Prev 2006;15:1083–94.
   PubMed Web of Science ®Google Scholar
• Webb PM, Hengels KJ, Moller H, Newell DG, Palli D, Elder JB, The epidemiology of low serum pepsinogen A levels and an international association with gastric cancer rates. EUROGAST Study Group. Gastroenterlogy 1994;107:1335–44.
   PubMed Web of Science ®Google Scholar
• Cryer B, Feldman M. Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans. Gastroenterolgy 1999;117:17–25.
   PubMed Web of Science ®Google Scholar
• Jevremovic D, Torbenson M, Murray J, Burqart LJ, Abraham SC. Atrophic autoimmune pangastritis: A distinctive form of antral and fundic gastritis associated with systemic autoimmune disease. Am J Surg Pathol 2006;30:1412–19.
   PubMed Web of Science ®Google Scholar
• Fontham ET, Ruiz B, Perez A, Hunter F, Correa P. Determinants of Helicobacter pylori infection and chronic gastritis. Am J Gastroenterol 1995;90:1094–101.
   PubMed Web of Science ®Google Scholar
• Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazaki T, Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 1992;102:760–6.
   PubMed Web of Science ®Google Scholar
• Sheu BS, Yang HB, Wang YL, Chuang CH, Huang AH, Wu JJ. Pre-treatment gastric histology is helpful to predict the symptomatic response after H. pylori eradication in patients with non-ulcer dyspepsia. Dig Dis Sci 2001;46:2700–7.
   PubMed Web of Science ®Google Scholar
• Eshmuratov A, Nah JC, Kim N, Lee HS, Lee HE, Lee BH, The correlation of endoscopic and histological diagnosis of gastric atrophy. Dig Dis Sci 2010;55:1364–75.
   PubMed Web of Science ®Google Scholar